Risk of Bundibugyo virus transmission through substances of human origin in the European Union/European Economic Area (EU/EEA)

Public health guidance
The outbreak of Ebola disease caused by Bundibugyo virus (BDBV, Orthoebolavirus bundibugyoense), currently affecting the Democratic Republic of the Congo (DRC) and Uganda, draws attention to the potential risk of BDBV transmission via donated blood and blood components, cells, tissues and organs – i.e. substances of human origin (SoHO).

Background

Ebola disease is caused by viruses in the Orthoebolavirus genus. Three orthoebolaviruses are known to cause large outbreaks: BDBV, Ebola virus (EBOV, previously known as Zaire ebolavirus), and Sudan virus (SUDV). The typical incubation period for Ebola disease ranges from two to 21 days (mean: six days). The prodromal phase lasts for up to 10 days, during which the infected individual experiences a sudden onset of flu-like illness. This is followed by progressive weakness, anorexia, diarrhoea, nausea, and vomiting. The next stage of the disease is characterised by gastrointestinal, neurological, vascular, cutaneous and respiratory symptoms. Haemorrhagic manifestations may also occur. During the final stage, patients may die from a combination of multi-organ failure and hypovolemic shock due to severe fluid loss. 

Key findings and recommendations

Risk assessment

  • The overall risk of Bundibugyo virus transmission through substances of human origin (SoHO) in the European Union/European Economic Area (EU/EEA) is currently assessed as very low.

Recommendations

  • ECDC recommends temporary deferral of asymptomatic individuals donating SoHO for at least six weeks after arriving from areas with Bundibugyo virus community transmission.
  • In the context of the current Ebola disease outbreak, individuals who are being monitored due to contact with a patient with an infection, or other exposure to Bundibugyo virus are ineligible to donate SoHO for at least six weeks from the beginning of the monitoring period
  • ECDC recommends a permanent deferral from donation of blood, cells and tissues for donors who have recovered from Ebola disease.
  • ECDC recommends that individuals who have had sexual contact with persons who have recovered from Ebola disease should be deferred from donating SoHO for at least six weeks after exposure, irrespective of the time elapsed since the recovery of the convalescent sexual contact.
Publication file

Risk of Bundibugyo virus transmission through substances of human origin in the European Union/European Economic Area (EU/EEA)

English (250.38 KB - PDF)

Read more about the outbreak here

Share this page